A detailed history of Venture Visionary Partners LLC transactions in Purple Biotech Ltd. stock. As of the latest transaction made, Venture Visionary Partners LLC holds 15,553 shares of PPBT stock, worth $6,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,553
Previous 15,553 -0.0%
Holding current value
$6,376
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$0.78 - $1.67 $772 - $1,654
991 Added 6.81%
15,553 $12,000
Q3 2023

Oct 13, 2023

BUY
$1.02 - $1.49 $860 - $1,257
844 Added 6.15%
14,562 $17,000
Q2 2023

Jul 14, 2023

BUY
$1.38 - $2.05 $896 - $1,332
650 Added 4.97%
13,718 $19,000
Q2 2022

Jul 26, 2022

BUY
$2.39 - $4.15 $4,780 - $8,300
2,000 Added 18.07%
13,068 $31,000
Q4 2021

Feb 08, 2022

BUY
$3.75 - $4.67 $3,750 - $4,670
1,000 Added 9.93%
11,068 $43,000
Q3 2021

Oct 20, 2021

BUY
$4.4 - $5.59 $44,299 - $56,280
10,068 New
10,068 $46,000

Others Institutions Holding PPBT

About PURPLE BIOTECH LTD.


  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $7.5M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.